CY1036A - N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyolbenzamide and derivatives - Google Patents

N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyolbenzamide and derivatives

Info

Publication number
CY1036A
CY1036A CY1036A CY103677A CY1036A CY 1036 A CY1036 A CY 1036A CY 1036 A CY1036 A CY 1036A CY 103677 A CY103677 A CY 103677A CY 1036 A CY1036 A CY 1036A
Authority
CY
Cyprus
Prior art keywords
sulphamoyolbenzamide
pyrrolidylmethyl
dimethoxy
allyl
derivatives
Prior art date
Application number
CY1036A
Other languages
English (en)
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of CY1036A publication Critical patent/CY1036A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY1036A 1976-07-19 1977-05-24 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyolbenzamide and derivatives CY1036A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (1)

Publication Number Publication Date
CY1036A true CY1036A (en) 1980-08-01

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1036A CY1036A (en) 1976-07-19 1977-05-24 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyolbenzamide and derivatives

Country Status (38)

Country Link
US (1) US4499019A (el)
JP (1) JPS5338631A (el)
AR (1) AR214330A1 (el)
AT (1) AT365570B (el)
AU (1) AU509291B2 (el)
BE (1) BE856289A (el)
CH (1) CH627162A5 (el)
CS (1) CS219885B2 (el)
CY (1) CY1036A (el)
DD (2) DD137670A5 (el)
DK (1) DK156646C (el)
EG (1) EG12911A (el)
ES (1) ES460621A1 (el)
FI (1) FI67213C (el)
FR (1) FR2358892A1 (el)
GB (1) GB1539319A (el)
GR (1) GR60836B (el)
HK (1) HK17880A (el)
HU (1) HU174981B (el)
IE (1) IE46171B1 (el)
IL (1) IL52547A (el)
IN (1) IN146993B (el)
LU (1) LU77782A1 (el)
MC (1) MC1153A1 (el)
MX (1) MX4711E (el)
NL (1) NL174347C (el)
NO (1) NO146598C (el)
NZ (1) NZ184634A (el)
OA (1) OA05704A (el)
PH (1) PH12838A (el)
PL (1) PL104244B1 (el)
PT (1) PT66819B (el)
RO (1) RO71691A (el)
SE (1) SE425243B (el)
SU (1) SU695556A3 (el)
YU (1) YU40677B (el)
ZA (1) ZA774256B (el)
ZM (1) ZM5477A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
AU509291B2 (en) 1980-05-01
CH627162A5 (el) 1981-12-31
DD132492A5 (de) 1978-10-04
PH12838A (en) 1979-09-05
FI67213C (fi) 1985-02-11
FI67213B (fi) 1984-10-31
DD137670A5 (de) 1979-09-19
RO71691A (ro) 1982-09-09
NO146598C (no) 1982-11-03
IE46171B1 (en) 1983-03-23
AU2702677A (en) 1979-01-18
SE7708176L (sv) 1978-01-20
ES460621A1 (es) 1978-05-01
DK156646C (da) 1990-02-05
FR2358892A1 (fr) 1978-02-17
NL174347C (nl) 1984-06-01
FI772214A (el) 1978-01-20
SE425243B (sv) 1982-09-13
PL199723A1 (pl) 1978-04-24
PL104244B1 (pl) 1979-08-31
ATA511677A (de) 1981-06-15
PT66819B (fr) 1978-12-22
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
AR214330A1 (es) 1979-05-31
IL52547A0 (en) 1977-10-31
US4499019A (en) 1985-02-12
AT365570B (de) 1982-01-25
OA05704A (fr) 1981-05-31
NL174347B (nl) 1984-01-02
IL52547A (en) 1980-01-31
NO772530L (no) 1978-01-20
YU40677B (en) 1986-04-30
JPS554724B2 (el) 1980-01-31
NO146598B (no) 1982-07-26
MC1153A1 (fr) 1978-04-17
JPS5338631A (en) 1978-04-08
NZ184634A (en) 1978-11-13
SU695556A3 (ru) 1979-10-30
IE46171L (en) 1978-01-19
HK17880A (en) 1980-04-11
CS219885B2 (en) 1983-03-25
IN146993B (el) 1979-10-20
NL7707982A (nl) 1978-01-23
DK326377A (da) 1978-01-20
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
EG12911A (en) 1980-12-31
MX4711E (es) 1982-08-11
DK156646B (da) 1989-09-18
GR60836B (en) 1978-08-31
HU174981B (hu) 1980-04-28
LU77782A1 (el) 1977-10-17
PT66819A (fr) 1977-08-01
YU173977A (en) 1983-01-21
FR2358892B1 (el) 1978-12-15

Similar Documents

Publication Publication Date Title
NZ192231A (en) 2-chloro-5-trichloromethyl-pyridine and 2,3-dichloro-5-trichloromethylpyridine
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
PH16512A (en) N-(phenylalkylamino-alkyl)-dihydroisoquinolinones,pharmaceutical compositions and methods employing them
ZA783669B (en) N'-phenyl-n-methyl-urea derivatives,and their production and use
JPS52148061A (en) 66carboxymethyl thiocortisol and derivatives thereof
GB1542361A (en) 1,4-benzo-dioxan derivatives
CY1036A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyolbenzamide and derivatives
MY8200038A (en) N-(1,3,4-thiadiazol-2yl)benzamides and their use as insecticides
PH15115A (en) Carbostyril and 3,4 dihydrocarbostyril
GB2048254B (en) 19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
NZ184529A (en) 5-isopropylidene-7-hydroxy-9-substituted-2,6-methano-3,4,56-tetrahydro-2h-1-benzoxocins and their preparation
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
GB1533820A (en) Substituted 1,3-diphenoxypropan-2-ol derivatives and their manufacture and use
GB1553321A (en) 1,2-epoxycholestene compounds their preparation and use
IL51260A (en) 2,2-disubstituted-phenylcarbamoyl-6-hydroxy-m-dioxin-4-one derivatives, their preparation and their use as insecticides
GB1538368A (en) 1,3,4,6-tetrathia and tetraselena-2,5-dihetero-pentalene compounds
GB2075982B (en) 1-3-dihydroxy-27-nor-cholesta-5-en and 5,7-dien-25-one
GB1544041A (en) N-substituted 7-amino-1,3,5-triaza-adamantane compounds their preparation and use
GB2030977B (en) 2,1-benzisothiazoles and preparation thereof
HK12283A (en) N-(1,3,4-thiadiazol-2-4l)benzamides
NZ185996A (en) 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions
IT1077596B (it) 1,3-diidro-1'-dimetilfosfinilalchil-3-fenilspiro isobenzofurani
GB1540347A (en) 4-pyridyl-formimidoylglycyl-d-phenyl-glycine and derivatives
IL53652A0 (en) New 1,4-oxathianes and the preparation thereof
NZ184908A (en) N-(2,6-dichlorophenyl)-2-aminopyrimidine and analgesic compositions